Janneke C Ham

2PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jan 07, 2020
Methotrexate plus or minus cetuximab as first-line treatment in a recurrent or metastatic (R/M) squamous cell carcinoma population of the head and neck (SCCHN), unfit for cisplatin combination treatment, a phase Ib-randomized phase II study Commence.

Janneke C Ham, Esther van Meerten, W Edward Fiets

|Apr 20, 2019
Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study).

Chantal M Driessen, Janneke C Ham, Maroeska Te Loo

Pageof 1

Frequent Collaborators

1 joint publications

Maroeska Te Loo

1 joint publications

Maurits van Lamoen